Physicochemical characterization and antimicrobial activity of benzathine penicillin G liposomes

S.T.P. Pharma Sciences

Volumn 9, Issue 5, 1999, Pages 419-427

  De Oliveira Pontes, A C ^a   Pisciottano Caetano, M N ^a   Santos Magalhaes, N S ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Antimicrobial activity; Egg phosphatidylcholine; Liposomes; Penicillin; Rheumaticfever; Staphylococcus aureus; Streptococcus pyogenes

Indexed keywords

AMPICILLIN; BENZATHINE PENICILLIN; DOXORUBICIN; LIPOSOME; NYSTATIN; PROSTAGLANDIN E1;

ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING KINETICS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; ELECTRIC CONDUCTIVITY; LIPID MEMBRANE; PHYSICAL CHEMISTRY; STREPTOCOCCUS PYOGENES;

EID: 0033298551     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Acute rheumatic fever
2. Miscellaneous neurologic, cardiac, pulmonary and metabolic disorders with rheumatic fever manifestations
3. Rheumatic heart disease
4. Prophylaxis against group A streptococcal infections in rheumatic fever patients
5. Niveis Sericos da Penicilina G Benzatina apos Administracao Intramuscular
6. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children with rheumatic fever and controls
7. Benzathine penicillin G and miocamycin in the treatment of children with streptococcal pharyngitis: A controlled therapeutic trial
8. A review of the rational and advantages of various mixtures of benzathine penicillin G
9. Evaluation of nanoparticles as drug-delivery systems I: Preparation Methods
10. Nanoparticle characterization a comprehensive physicochemical approach
11. Vectorization et vecteurs des medicaments
12. Polymeric drug and drug delivery systems-Liposomes
13. Liposomes-trapped penicillin in growth inhibition of some penicillin-resistant bacteria
14. Protection of insulin from enzymatic degradation by its association to liposomes
15. Optimization and upscaling of doxorubicin-containing liposomes for clinical use
16. Encapsulation of ampicillin in reverse-phase evaporation liposomes: A direct evaluation by derivative spectrophotometry
17. Association of polyene antibiotics with sterol-free lipid membranes to dilauroylphosphatidylcholine bilayers
18. Immunological adjuvants a role for liposomes
19. The preparation and characterization of immunoliposomes for targeting to tumor or cells
20. Liposomes in the treatment of malignancy: A clinical perspective
21. Association and release of prostaglandin E1 from liposomes
22. Entrapment of nucleic acids in liposomes
23. Gene therapy, concepts, current trials and future directions
24. Liposomes in drug delivery: Clinical, diagnostic and ophthalmic potential
25. Characterisation and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles
26. The stability and in vitro release kinetics of a clofibride emulsion
27. A new scanning electron microscope (SEM) method for the determination of particle size in parenteral fat emulsions
28. Design and charactrization of of a submicronized o/w emulsion of diazepam for parenteral use
29. Liposomes as agents of DNA transfer
30. A sample method for the preparations of liposomes for pharmaceutical applications: Characterization of the liposomes
31. The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo
32. Submicron emulsions as colloidal drug carries for intravenous administration: Comprehensive physicochemical characterization
33. Ampicillin-loaded liposomes and nanoparticles: Comparison of drug loading, drug release and in vitro antimicrobial activity
34. An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylatic acid nanocapsules of clofibride